Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -240,649 | -149,753 | -65,047 | -234,330 | -168,645 |
| Depreciation Amortization | 1,932 | 1,291 | 659 | 2,560 | 1,894 |
| Income taxes - deferred | -2,084 | -1,383 | -1,213 | -8,864 | -252 |
| Accounts receivable | 663 | 380 | -7,178 | -614 | -67 |
| Other Working Capital | -4,608 | -9,571 | -12,194 | 5,713 | 2,623 |
| Other Operating Activity | 47,109 | 33,151 | 23,321 | 54,146 | 37,443 |
| Operating Cash Flow | $-197,637 | $-125,885 | $-61,652 | $-181,389 | $-127,004 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 155,782 | 116,970 | 34,553 | 168,075 | 68,789 |
| PPE Investments | -481 | -200 | -43 | -3,075 | -2,292 |
| Investing Cash Flow | $155,301 | $116,770 | $34,510 | $165,000 | $66,497 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,576 | 1,216 | 1,151 | 12,130 | N/A |
| Financing Cash Flow | $3,576 | $1,216 | $1,151 | $12,130 | $N/A |
| Exchange Rate Effect | 562 | 568 | -64 | -1,672 | -515 |
| Beginning Cash Position | 142,712 | 142,712 | 142,712 | 148,643 | 148,643 |
| End Cash Position | 104,514 | 135,381 | 116,657 | 142,712 | 87,621 |
| Net Cash Flow | $-38,198 | $-7,331 | $-26,055 | $-5,931 | $-61,022 |
| Free Cash Flow | |||||
| Operating Cash Flow | -197,637 | -125,885 | -61,652 | -181,389 | -127,004 |
| Capital Expenditure | -481 | -200 | -43 | -3,075 | -2,292 |
| Free Cash Flow | -198,118 | -126,085 | -61,695 | -184,464 | -129,296 |